Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers. Jun 2007 - Cancer Immunol. Immunother.; 56(9):0340-7004 [PMID:17285289] [Svane IM] [Pedersen AE] [Johansen JS] [Johnsen HE] [Nielsen D] [Kamby C] [Ottesen S] [Balslev E] [Gaarsdal E] [Nikolajsen K] [Claesson MH]
